Efectividad de la vacuna BNT162b2 en el personal del Centro de Salud de Jávea
Open Access
- 31 July 2021
- journal article
- letter
- Published by Elsevier BV in Gaceta Sanitaria
- Vol. 36 (1), 89-90
- https://doi.org/10.1016/j.gaceta.2021.06.005
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance dataThe Lancet, 2021
- Prospects for durable immune control of SARS-CoV-2 and prevention of reinfectionNature Reviews Immunology, 2021
- Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational studyThe Lancet Infectious Diseases, 2021
- Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasmaClinica Chimica Acta; International Journal of Clinical Chemistry, 2020